Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data

Kim WY, Rose T, Roghmann F, Eckstein M, Jarczyk J, Zengerling F, Sikic D, Breyer J, Bolenz C, Hartmann A, Mayhew G, Shibata Y, Uronis J, Galluzzi A, Sundaram R, Xia Q, Wu K, Santiago-Walker A, Erben P, Wirtz R (2020)


Publication Type: Conference contribution

Publication year: 2020

Journal

Publisher: AMER SOC CLINICAL ONCOLOGY

City/Town: ALEXANDRIA

Conference Proceedings Title: JOURNAL OF CLINICAL ONCOLOGY

Event location: San Francisco, CA US

DOI: 10.1200/jco.2020.38.6_suppl.493

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Kim, W.Y., Rose, T., Roghmann, F., Eckstein, M., Jarczyk, J., Zengerling, F.,... Wirtz, R. (2020). Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data. In JOURNAL OF CLINICAL ONCOLOGY. San Francisco, CA, US: ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

MLA:

Kim, William Y., et al. "Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data." Proceedings of the Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco, CA ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY, 2020.

BibTeX: Download